Cirka tre fjerdedele af hundene fik Yarvitan, mens resten fik medicinen i en formulering, hvor det aktive stof var fjernet (kontrolgruppen).
About three-quarters received Yarvitan while the remainder received the medicine with the active substance removed (control group).